What is Inogen?
Headquartered in Goleta, California, and established in 2001, Inogen is a medical technology company dedicated to developing and manufacturing portable oxygen concentrators. These devices are crucial for providing supplemental long-term oxygen therapy to patients managing chronic respiratory conditions. The company's innovative solutions aim to enhance the quality of life for individuals requiring continuous oxygen support, positioning it as a key provider in the home healthcare market.
How much funding has Inogen raised?
Inogen has raised a total of $27.2M across 1 funding round:
Other Financing Round
$27.2M
Other Financing Round (2025): $27.2M with participation from Yuwell Global
Key Investors in Inogen
Yuwell Global
Yuwell Global specializes in the development and manufacturing of medical devices and healthcare products, including respiratory devices and monitoring systems. Their commitment to innovation aims to improve patient care and health outcomes.
What's next for Inogen?
This major enterprise-level funding signals a pivotal moment for Inogen, likely enabling accelerated product development, expanded market reach, and enhanced manufacturing capabilities. The strategic investment suggests a focus on scaling operations and solidifying its position within the competitive medical device industry. Future endeavors may include further technological advancements in portable oxygen therapy and broader distribution networks to serve a growing patient population.
See full Inogen company page
